{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:26:30Z","timestamp":1793521590538,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2023,5,1]]},"abstract":"\n Importance<\/jats:title>\n Exome sequencing is a first-tier diagnostic test for individuals with neurodevelopmental disorders, including intellectual disability\/developmental delay and autism spectrum disorder; however, this recommendation does not include cerebral palsy.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate if the diagnostic yield of exome or genome sequencing in cerebral palsy is similar to that of other neurodevelopmental disorders.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n The study team searched PubMed for studies published between 2013 and 2022 using cerebral palsy and genetic testing terms. Data were analyzed during March 2022.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Studies performing exome or genome sequencing in at least 10 participants with cerebral palsy were included. Studies with fewer than 10 individuals and studies reporting variants detected by other genetic tests were excluded. Consensus review was performed. The initial search identified 148 studies, of which 13 met inclusion criteria.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n \n Data were extracted by 2 investigators and pooled using a random-effects meta-analysis. Incidence rates with corresponding 95% CIs and prediction intervals were calculated. Publication bias was evaluated by the Egger test. Variability between included studies was assessed via heterogeneity tests using the\n \n I\n 2<\/jats:sup>\n <\/jats:italic>\n statistic.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the pooled diagnostic yield (rate of pathogenic\/likely pathogenic variants) across studies. Subgroup analyses were performed based on population age and on the use of exclusion criteria for patient selection.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Thirteen studies were included consisting of 2612 individuals with cerebral palsy. The overall diagnostic yield was 31.1% (95% CI, 24.2%-38.6%;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u200991%). The yield was higher in pediatric populations (34.8%; 95% CI, 28.3%-41.5%) than adult populations (26.9%; 95% CI, 1.2%-68.8%) and higher among studies that used exclusion criteria for patient selection (42.1%; 95% CI, 36.0%-48.2%) than those that did not (20.7%; 95% CI, 12.3%-30.5%).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this systematic review and meta-analysis, the genetic diagnostic yield in cerebral palsy was similar to that of other neurodevelopmental disorders for which exome sequencing is recommended as standard of care. Data from this meta-analysis provide evidence to support the inclusion of cerebral palsy in the current recommendation of exome sequencing in the diagnostic evaluation of individuals with neurodevelopmental disorders.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2023.0008","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:02:20Z","timestamp":1678100540000},"page":"472","source":"Crossref","is-referenced-by-count":103,"title":["Diagnostic Yield of Exome Sequencing in Cerebral Palsy and Implications for Genetic Testing Guidelines"],"prefix":"10.1001","volume":"177","author":[{"given":"Pedro J.","family":"Gonzalez-Mantilla","sequence":"first","affiliation":[{"name":"Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Myers","sequence":"additional","affiliation":[{"name":"Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Finucane","sequence":"additional","affiliation":[{"name":"Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Ledbetter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Moreno-De-Luca","sequence":"additional","affiliation":[{"name":"Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania"},{"name":"Department of Radiology, Geisinger, Danville, Pennsylvania"},{"name":"Diagnostic Medicine Institute, Geisinger, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"poi230001r1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(13)70011-5","article-title":"Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.","volume":"12","author":"Moreno-De-Luca","year":"2013","journal-title":"Lancet Neurol"},{"issue":"s109","key":"poi230001r2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/dmcn.2007.49.issue-s109","article-title":"A report: the definition and classification of cerebral palsy April 2006.","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev Med Child Neurol Suppl"},{"issue":"4","key":"poi230001r3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/dmcn.2014.56.issue-4","article-title":"What constitutes cerebral palsy in the twenty-first century?","volume":"56","author":"Smithers-Sheedy","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"poi230001r4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis.","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"poi230001r5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.dhjo.2019.01.005","article-title":"Prevalence of cerebral palsy, intellectual disability, hearing loss, and blindness, National Health Interview Survey, 2009-2016.","volume":"12","author":"McGuire","year":"2019","journal-title":"Disabil Health J"},{"issue":"7","key":"poi230001r6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/dmcn.2018.60.issue-7","article-title":"Intellectual disability in cerebral palsy: a population-based retrospective study.","volume":"60","author":"Reid","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"poi230001r7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/dmcn.v62.1","article-title":"Comorbidities in cerebral palsy: a patient registry study.","volume":"62","author":"Hollung","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"poi230001r8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/dmcn.13436","article-title":"Prevalence and characteristics of autism spectrum disorders in children with cerebral palsy.","volume":"59","author":"Delobel-Ayoub","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"poi230001r9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/dmcn.v62.12","article-title":"Speech in children with cerebral palsy.","volume":"62","author":"Mei","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"poi230001r10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41582-018-0043-6","article-title":"The complex aetiology of cerebral palsy.","volume":"14","author":"Korzeniewski","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"poi230001r11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/GRF.0b013e318187087c","article-title":"Causative factors in cerebral palsy.","volume":"51","author":"Nelson","year":"2008","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"poi230001r12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/dmcn.2013.55.issue-3","article-title":"The association of cerebral palsy with birth asphyxia: a definitional quagmire.","volume":"55","author":"Ellenberg","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"poi230001r13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1474-4422(11)70287-3","article-title":"Genetic insights into the causes and classification of the cerebral palsies.","volume":"11","author":"Moreno-De-Luca","year":"2012","journal-title":"Lancet Neurol"},{"issue":"1","key":"poi230001r14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ejhg.2013.93","article-title":"Rare copy number variation in cerebral palsy.","volume":"22","author":"McMichael","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"16","key":"poi230001r15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/WNL.0000000000001494","article-title":"Copy number variations in cryptogenic cerebral palsy.","volume":"84","author":"Segel","year":"2015","journal-title":"Neurology"},{"key":"poi230001r16","doi-asserted-by":"publisher","first-page":"7949","DOI":"10.1038\/ncomms8949","article-title":"Clinically relevant copy number variations detected in cerebral palsy.","volume":"6","author":"Oskoui","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"poi230001r17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/gim.2017.83","article-title":"De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy.","volume":"20","author":"Zarrei","year":"2018","journal-title":"Genet Med"},{"issue":"8","key":"poi230001r18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/jmedgenet-2021-107884","article-title":"Diagnostic yield of chromosomal microarray and trio whole exome sequencing in cryptogenic cerebral palsy.","volume":"59","author":"Yechieli","year":"2022","journal-title":"J Med Genet"},{"issue":"2","key":"poi230001r19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/mp.2014.189","article-title":"Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy.","volume":"20","author":"McMichael","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"5","key":"poi230001r20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/acn3.2018.5.issue-5","article-title":"Genomic analysis identifies masqueraders of full-term cerebral palsy.","volume":"5","author":"Takezawa","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"poi230001r21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s41436-018-0376-y","article-title":"Atypical cerebral palsy: genomics analysis enables precision medicine.","volume":"21","author":"Matthews","year":"2019","journal-title":"Genet Med"},{"issue":"2","key":"poi230001r22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41390-020-01250-3","article-title":"Hidden etiology of cerebral palsy: genetic and clinical heterogeneity and efficient diagnosis by next-generation sequencing.","volume":"90","author":"Rosello","year":"2021","journal-title":"Pediatr Res"},{"issue":"10","key":"poi230001r23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41588-020-0695-1","article-title":"Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.","volume":"52","author":"Jin","year":"2020","journal-title":"Nat Genet"},{"issue":"1","key":"poi230001r24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41525-021-00238-0","article-title":"Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing.","volume":"6","author":"van Eyk","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"5","key":"poi230001r25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jama.2020.26148","article-title":"Molecular diagnostic yield of exome sequencing in patients with cerebral palsy.","volume":"325","author":"Moreno-De-Luca","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"poi230001r26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/dmcn.v63.12","article-title":"Genetic testing in individuals with cerebral palsy.","volume":"63","author":"May","year":"2021","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"poi230001r27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awab209","article-title":"In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy.","volume":"145","author":"Li","year":"2022","journal-title":"Brain"},{"key":"poi230001r28","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.734946","article-title":"Genetic testing in various neurodevelopmental disorders which manifest as cerebral palsy: a case study from Iran.","volume":"9","author":"Nejabat","year":"2021","journal-title":"Front Pediatr"},{"issue":"4","key":"poi230001r29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ymgme.2021.07.007","article-title":"Genomics in cerebral palsy phenotype across the lifespan: comparison of diagnostic yield between children and adult population.","volume":"137","author":"Al Zahrani","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"2","key":"poi230001r30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/acn3.v9.2","article-title":"Mendelian etiologies identified with whole exome sequencing in cerebral palsy.","volume":"9","author":"Chopra","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"poi230001r31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jpeds.2021.11.019","article-title":"Genetic spectrum identified by exome sequencing in a Chinese pediatric cerebral palsy cohort.","volume":"242","author":"Mei","year":"2022","journal-title":"J Pediatr"},{"issue":"10","key":"poi230001r32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41436-020-0913-3","article-title":"Correction: Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.","volume":"22","author":"Srivastava","year":"2020","journal-title":"Genet Med"},{"issue":"11","key":"poi230001r33","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).","volume":"23","author":"Manickam","year":"2021","journal-title":"Genet Med"},{"issue":"4","key":"poi230001r35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial.","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"poi230001r36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"JSS Journal of Statistical Software"},{"key":"poi230001r37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-018-0073-4","article-title":"Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy.","volume":"3","author":"Corbett","year":"2018","journal-title":"NPJ Genom Med"},{"issue":"3","key":"poi230001r38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpn.2019.02.001","article-title":"The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center.","volume":"23","author":"Zouvelou","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"poi230001r39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"poi230001r40","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.526779","article-title":"Genetic testing in neurodevelopmental disorders.","volume":"9","author":"Savatt","year":"2021","journal-title":"Front Pediatr"},{"issue":"9","key":"poi230001r41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.tig.2014.07.001","article-title":"Ten years of next-generation sequencing technology.","volume":"30","author":"van Dijk","year":"2014","journal-title":"Trends Genet"},{"issue":"5","key":"poi230001r42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40291-021-00541-7","article-title":"Clinical exome reanalysis: current practice and beyond.","volume":"25","author":"Ji","year":"2021","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"poi230001r43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymgme.2021.07.004","article-title":"Genetic counseling considerations in cerebral palsy.","volume":"137","author":"Elliott","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"5","key":"poi230001r44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/15592294.2020.1809871","article-title":"Germline DNMT3A mutation in familial acute myeloid leukaemia.","volume":"16","author":"DiNardo","year":"2021","journal-title":"Epigenetics"},{"issue":"2","key":"poi230001r45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jnnp-2017-315653","article-title":"GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS.","volume":"89","author":"Waak","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 1","key":"poi230001r46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"poi230001r34","unstructured":"RStudio Team. RStudio: integrated development for R. Accessed January 30, 2023. https:\/\/www.rstudio.com\/"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2801964\/jamapediatrics_gonzalezmantilla_2023_oi_230001_1682695695.13866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T11:03:58Z","timestamp":1682939038000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2801964"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2023.0008","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}